Comparable efficacy-safety and better renal function with everolimus and reduced-exposure tacrolimus versus standard-exposure tacrolimus in liver transplant recipients: H2304 and H2307 pooled analysis

被引：0

作者：

Levy, G. ^{[1
]}

Lee, S. G. ^{[2
]}

Jeng, L. -B ^{[3
]}

Soin, A. S. ^{[4
]}

Lee, W. -C ^{[5
]}

De Simone, P. ^{[6
]}

Nevens, F. ^{[7
]}

Suh, K. -S ^{[8
]}

Fischer, L. ^{[9
]}

Joo, D. J. ^{[10
]}

Fung, J. ^{[11
]}

Joh, J. -W ^{[12
]}

Kaido, T. ^{[13
]}

Grant, D. ^{[14
]}

Meier, M. ^{[15
]}

Sips, C. ^{[15
]}

Kaneko, S. ^{[16
]}

Saliba, F. ^{[17
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Asan Med Ctr, Seoul, South Korea

[3] China Med Univ Hosp, Taichung, Taiwan

[4] Medic Hosp, Medanta, Gurgaon, India

[5] Chang Gung Mem Hosp, Taoyuan, Taiwan

[6] Azienda Osped Univ Pisana, Pisa, Italy

[7] Univ Hosp Gasthuisberg, Leuven, Belgium

[8] Seoul Natl Univ, Coll Med, Seoul, South Korea

[9] Univ Med Ctr Eppendorf, Hamburg, Germany

[10] Yonsei Univ, Coll Med, Seoul, South Korea

[11] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA

[12] Samsung Med Ctr, Seoul, South Korea

[13] Kyoto Univ Hosp, Kyoto, Japan

[14] Toronto Gen Hosp, Toronto, ON, Canada

[15] Novartis Pharma AG, Basel, Switzerland

[16] Novartis Pharma KK, Tokyo, Japan

[17] Hop Paul Brousse, Villejuif, France

来源：

TRANSPLANTATION | 2019年 / 103卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

O-059

引用

页码：36 / 36

页数：1

共 47 条

[41] Efficacy and Safety of Everolimus with Reduced Tacrolimus or Cyclosporine in Pediatric Liver Transplant Recipients: 12-Month Results from H2305 Study
Weymann, A.
Ganschow, R.
Ericzon, B.
Dhawan, A.
Sharif, K.
Martzloff, E. -D.
Rauer, B.
Ng, J.
Lopez, P.
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 234 - 234
[42] Effect of everolimus plus reduced-dose tacrolimus in de novo living-donor liver transplantation recipients on recurrence of HCC: 24 months subgroup analysis from the H2307 study
Jeng, L. -B.
Lee, S. -G.
Soin, A. S.
Lee, W. -C.
Suh, K. -S.
Joo, D. J.
Uemoto, S.
Meier, M.
Kochuparampil, J.
Sips, C.
Kaneko, S.
Levy, G.
TRANSPLANTATION, 2018, 102 : 300 - 301
[43] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Kaiser, G. M.
Saliba, F.
Jonas, S.
Duvoux, C.
Dong, G.
Junge, G.
Lopez, P.
De Simone, P.
JOURNAL OF HEPATOLOGY, 2013, 58 : S12 - S12
[44] EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
Fung, J.
Fischer, L.
Kaiser, G.
Jonas, S.
Heise, M.
Schemmer, P.
Pascher, A.
Schlitt, H.
Paulus, E.
Mertens, M.
Nevens, F.
TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
[45] Rationale and Design of a 24-Month, Prospective, International Study Assessing the Efficacy, Safety and Tolerability of Everolimus with Reduced Exposure to Cyclosporine or Tacrolimus in Pediatric Liver Transplant Recipients.
Ganschow, R.
Fischer, L.
Torre, G.
Langer, R. M.
Ericzon, B. G.
Brunati, A.
Sips, C.
Balfour, A.
Junge, G.
LIVER TRANSPLANTATION, 2013, 19 : S176 - S176
[46] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION-24-MONTH RESULTS FROM H2305 STUDY.
Ganschow, R.
Ericzon, B. -G.
Dhawan, A.
Sharif, K.
Martzloff, E. -D.
Rauer, B.
Ng, J.
Lopez, P. M.
PEDIATRIC TRANSPLANTATION, 2017, 21 : 13 - 13
[47] EFFICACY AND SAFETY OF EVEROLIMUS (EVR) WITH REDUCED EXPOSURE TACROLIMUS OR CYCLOSPORINE IN PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS (PLTXR): 24-MONTH RESULTS FROM H2305-STUDY (NCT01598987)
Ganschow, R.
Ericzon, B. G.
Dhawan, A.
Sharif, K.
Martzloff, E. D.
Rauer, B.
Ng, J.
Lopez, P. M.
TRANSPLANT INTERNATIONAL, 2017, 30 : 37 - 37

← 1 2 3 4 5 →